Epilepsy Research UK invests in clinical and fundamental scientific research investigating the causes, diagnosis and clinical management of epilepsy and associated conditions.

We are currently in the process of refreshing our research strategy.

As a member of the Association of Medical Research Charities, we are committed to adhering to the principles and practices of effective grant management, including the AMRC’s five principles of peer review. Learn more about our research funding process and AMRC membership below. As part of our annual grant round we offer three types of research grant.

OUR GRANT FUNDING PROCESS

As part of our annual grant round we offer three types of research grant:

Emerging leader fellowship stacked

Up to £300,000 across 4 years

Awarded to an early career researcher to develop their skills and knowledge in order to become a leader in epilepsy research.

Endeavour project grants stacked

Up to £200,000 across 3 years

Awarded to a team with a track record in epilepsy research to investigate a research question based on prior evidence.

pilot studies stacked

Up to £30,000 across 2 years

Awarded to a research team to test a novel research idea and provide evidence to leverage larger funding amounts

Our open competition annual grant round that lasts approximately 9 months

STAGE 1 ERUK’s grant round opens for ten weeks from mid-July, inviting high quality fundamental science and clinical research preliminary applications

STAGE 2 Preliminary applications are shortlisted by our Scientific Advisory Committee (SAC) in November

STAGE 3 Shortlisted applicants are invited to submit a full research application, which is sent externally for independent peer review

STAGE 4 The SAC rigorously review each research application, taking into consideration the peer review comments

STAGE 5 The SAC meet in March and recommend the highest-scored research applications to the Board of Trustees for funding

SCIENTIFIC ADVISORY COMMITTEE (SAC)

Epilepsy Research UK’s SAC is a panel of the UK’s leading neurologists, neuroscientists, and epilepsy researchers. These epilepsy research experts sit alongside non-scientific “Experts by Experience” and advise the Board of Trustees on scientific matters, including the annual research grant funding process. Meet the committee below:

Our SAC members

BF SAC

Prof Bruno Frenguelli (Chair)
Professor of Neuroscience
Warwick University

Mike square

Prof Michael Cousin
Chair of Neuronal Cell Biology
University of Edinburgh

bagshaw-andy-230x230

Dr Andy Bagshaw
Reader in Neuroimaging
University of Birmingham

Hannah square

Prof Hannah Cock
Professor of Epilepsy & Medical Education
MBBS Course Director, Institute Information Governance Lead
St George’s University Hospital

Manju square

Prof Manju Kurian
Professor of Paediatric Neurology
Great Ormond Street Hospital

John Terry Square

Prof John Terry
Professor of Biomedical Modelling
University of Birmingham

Gavin Square

Prof Gavin Woodhall
Professor of Neurophysiology
Aston University

Markus SAC

Prof Markus Reuber
Professor of Neuropsychiatry
University of Sheffield

Torie Robinson
CEO
Epilepsy Sparks

SK SAC square

Dr Simon Keller
Reader in Imaging Neuroscience
University of Liverpool

Kate square

Dr Kate Baker
Programme Leader Track Scientist
MRC Cognition and Brain Sciences Unit
University of Cambridge

Andrew square

Prof Andrew Trevelyan
Professor of Network Neuroscience
Newcastle University

AMRC membership

Membership of the Association of Medical Research Charities (AMRC) is the hallmark of quality and credibility. It means we fund high-quality research that is associated with a published research strategy and has a robust peer-review process and an exhaustive conflicts of interest policy.

As members, our research procedures are audited every five years to ensure they meet the exacting membership standards. For universities, government and funding bodies, AMRC membership is a recognised indicator of quality. We also attend regular training alongside other research charities to develop best practice approaches and share learning.

amrc hop

Here’s a summary of the investment AMRC members make to improving healthcare:

Economic impact of research

  • Every £1 invested in medical research delivers a return equivalent to around 25p every year, for ever
  • Every £1 of public or charity investment in medical research is also associated with an additional £0.83-£1.07 of private sector R&D spend. This spill-over leads to a real annual rate of return on the investment of 15%-18%
  • Combined, the total annual rate of return on public or charitable investment in medical research is 24%-28

Medical research charities contributed

  • £1.6 billion of research funding in the UK in 2017
  • £13 billion in research in the UK since the sector started collecting data in 2008
  • AMRC members fund nearly half of all publicly funded medical research nationally
  • Capital investments of £71 million were made in the UK by charities in 2017
  • Over 17,000 researcher salaries were funded by medical research charities in 2017


Research involving humans

If an ERUK-funded study involves human participants, the researchers are required to have all relevant regulatory and ethical approvals in place.

Read more about research involving people with epilepsy here

Research involving animals

As a member of the Association of Medical Research Charities (AMRC), Epilepsy Research UK supports the principle of using animals in research. We believe it should only be used when there is no alternative but that it is an important part of the research process which helps to advance understanding of serious health conditions and to develop better treatments.

Read more about research involving animals here

Promoting, encouraging and funding research into the causes, diagnosis and clinical management of people with epilepsy and associated conditions

Read More Here

Developing the next generation of epilepsy researchers and capacity building the epilepsy research environment

Read More Here

Accelerating innovations for people with epilepsy by supporting research that will influence clinical practice and health policy

Read more here